The PR was published on:
VISIT US AT VITAFOODS ASIA
Frutarom Enters “Beauty from Within” Market in Asia
Pure tomato powder-derived ingredient backed by research boosts skin health and radiance
Frutarom enters the “beauty from within” market with PhytoflORAL®, a patented clinically studied cosmeceutical for skin lightening and photo protection. It was developed by IBR, Ltd., Israel. Frutarom will showcase PhytoflORAL® at VitaFoods Asia in Singapore, on September 11 – 12, 2018, at booth #H22.
PhytoflORAL® is a proprietary ingredient derived from non-GMO tomatoes rich in the colourless carotenoids, phytoene and phytofluene. It is available as a free-flowing, all-natural powder that can be used in multiple applications, including capsules, chewable tablets, drinks and pre-mix sachets.
“The recent acquisition of IBR by Frutarom opened a new market of cosmeceuticals, with prospects for rapid growth and added value,” says Yoni Glickman, President of Frutarom Natural Soutions. “IBR brings innovation and all-natural solutions backed by research that perfectly fit into our portfolio.”
Clinical data show that dietary intake of phytoene and phytofluene results in the accumulation of these phytochemicals in the skin, delivering multiple skin-health and beauty benefits. These include protection against oxidative and photo damage, as well as capabilities to lighten skin and even out complexion. Moreover, these compounds possess inherent anti-aging properties for skin. The carotenoids inhibit melanin synthesis and control pigmentation through natural mechanisms, protecting from UV and oxidative damage, while concurrently reducing inflammation and DNA damage.
In many cultures lighter skin is correlated with luxury and well-being, while even toned skin is universally translated into a healthier and more youthful appearance.
“Asia Pacific is one of the top markets for skin lightening ingredients,” explains Liki von Oppen-Bezalel, Ph.D., VP of Business Development and Marketing for IBR. “Multiple skin health ingredients, especially skin-whitening materials, are unsafe for use. This is why it was vital to develop a safe, research-backed natural ingredient like PhytoflORAL®.”
PhytoflORAL® has been subject to a number of clinical and in vitro studies that demonstrate its bioactivity. Efficacy was further elucidated through gene expression analysis.
In one clinical study, PhytoflORAL® presented a significant photoprotective effect after 84 days of supplementation, as indicated by a 20% increase in Minimum Erythemal Dose (calculates shortest exposure to UV radiation before reddening of the skin) in 65% of participants. Another study demonstrated a measurable skin lightening effect in 82% of subjects noticeable after 42 days, and increasing after 84 days. In addition, subjects reported enhanced skin radiance, evenness, hydration, and suppleness, and found their skin to be visually healthier and more resistant to sun damage. participants. Another study demonstrated a measurable skin
lightening effect in 82% of subjects noticeable after 42 days, and increasing after 84 days. In addition, subjects reported enhanced skin radiance, evenness, hydration, and suppleness, and found their skin to be visually healthier and more resistant to sun damage.
IBR developed complementary ingredients to PhytoflORAL® for topical use. These products also are rich in phytoene and phytofluene, and available for dual “beauty from inside and outside” regimes.
The global active ingredients market for cosmetics was valued at approx. US$2.63 billion in 2015. It is projected to reach US$4.45 billion by 2026, as reported in Markets and Markets. The primary drivers for this acceleration is increasing awareness among consumers toward skin health that is coupled with its beautiful appearance. The trend is especially strong in Asia and South America. This awareness is generating a significant demand for cosmetics and personal care products, particularly those for anti-aging, skin lightening, and sunscreen. The demand for natural, “green,” environmentally friendly cosmetic products is likewise increasing.
“These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease”